Stay updated on Risankizumab Maintenance in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab Maintenance in Psoriasis Clinical Trial page
- Check2 days agoChange DetectedThe footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record details, signaling restricted access to the content. Previous study content and related metadata are no longer visible.SummaryDifference17%

- Check23 days agoChange DetectedThe revision label in the documentation section was updated from v3.6.6 to v3.7.0. This reflects a new revision of the study documents.SummaryDifference0.0%

- Check37 days agoChange DetectedThe revision line now shows Revision: v3.6.6, replacing Revision: v3.6.5. This indicates an updated version of the study documents or related materials associated with the page.SummaryDifference0.0%

- Check44 days agoChange DetectedA line noting an NIH grant/contract funding source was added to the study details, clarifying the source of support for this risankizumab maintenance trial.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a small internal update to the page. It does not modify the study details, eligibility criteria, or results information, and seems to be an internal versioning change.SummaryDifference0.0%

Stay in the know with updates to Risankizumab Maintenance in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.